Open Philanthropy recommended a grant of $2,200,000 over three years to the University of Bonn to support work led by Professor Hiroki Kato on further developing a drug that inhibits influenza growth by inhibiting mRNA cap structure methylation.
This falls within Open Philanthropy’s focus area of scientific research, specifically within its interest in advancing human health and wellbeing.